Page last updated: 2024-12-08
11-deoxytetrodotoxin
Description
**11-Deoxytetrodotoxin (11-deoxyTTX)** is a structural analog of tetrodotoxin (TTX), a potent neurotoxin produced by various marine organisms like pufferfish.
**Key Features and Importance for Research:**
* **Structural Similarity to TTX:** 11-deoxyTTX shares a similar structure to TTX, with the key difference being the absence of a hydroxyl group at the 11-position. This structural similarity allows it to bind to the same target site as TTX, the voltage-gated sodium channels (VGSCs) in nerve cells.
* **Reduced Toxicity:** Compared to TTX, 11-deoxyTTX is significantly less toxic. This reduced toxicity makes it a valuable tool for research purposes.
* **Investigating VGSC Function:** 11-deoxyTTX is used as a probe to investigate the structure-function relationship of VGSCs. By comparing the effects of 11-deoxyTTX and TTX on neuronal activity, researchers can gain insights into the role of specific amino acid residues within the VGSC binding site.
* **Developing Therapeutics:** The reduced toxicity of 11-deoxyTTX has prompted research into its potential as a therapeutic agent. Studies are underway to explore its use in treating conditions like chronic pain, epilepsy, and neurological disorders.
* **Studying TTX Biosynthesis:** Understanding the biosynthesis of TTX is crucial for elucidating its toxic mechanisms and for developing strategies to mitigate its effects. 11-deoxyTTX serves as an intermediate in the biosynthesis of TTX, and its study provides valuable information about the enzymatic pathways involved.
**Overall, 11-deoxyTTX is a valuable research tool that provides insights into the structure, function, and biosynthesis of TTX. Its reduced toxicity compared to TTX makes it a promising candidate for therapeutic development.**
11-deoxytetrodotoxin: RN given refers to parent cpd; isolated from the newt Cynops ensicauda [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (7)
Synonym |
11-deoxytetrodotoxin |
tetrodoxin, 11-deoxy-, (4beta)- |
113564-23-1 |
CHEBI:196242 |
(1r,5s,6r,7r,9s,11s,13s,14s)-3-amino-14-methyl-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol |
C20026 |
DTXSID601019777 |
Drug Classes (2)
Class | Description |
organic heteromonocyclic compound | |
organonitrogen heterocyclic compound | Any organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.76
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.76 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.55 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |